Abstract Purpose of Review Obesity is a heterogeneous condition, yet sex/gender is rarely
considered in the prevention or clinical care of this disease. This review examined and …

In humans, the combination of all sex-specific genetic, epigenetic, and hormonal influences
of biologic sex produces different in vivo environments for male and female cells. We dissect …

Introduction Pharmacotherapy is a useful adjunct when patients with obesity are unable to
achieve adequate benefit from lifestyle interventions. Areas covered This review covers the …

Recent publicity around the use of new antiobesity medications (AOMs) has focused the
attention of patients and healthcare providers on the role of pharmacotherapy in the …

Abstract Purpose of Review This review provides an overview of the history, mechanism of
action, and expected treatment effects of the anti-obesity medication (AOM), phentermine. It …

Abstract Purpose of Review Eating disorders (EDs) and overweight/obesity (OW/OB) have a
significant impact on veterans. This review highlights current research on EDs and OW/OB in …

Abstract Background Anti-obesity medications (AOMs) can be initiated in conjunction with
participation in the VA national behavioral weight management program, MOVE!, to help …

Obesity is largely undertreated, in part because of the stigma surrounding the disease and
its treatment. The use of the term “weight loss drugs” to refer to medications for the treatment …

Recent publicity around the use of new antiobesity medications (AOMs) has focused the
attention of patients and healthcare providers on the role of pharmacotherapy in the …

Objective The prevalence of overweight and obesity among beneficiaries of the Military
Health System (MHS) is 41.6% and 30.5%, respectively. This incurs significant medical …